Oldenburg J - Search Results

1

Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: Recommendations from a German expert panel.

Escuriola-Ettingshausen C, Auerswald G, Königs C, Kurnik K, Scholz U, Klamroth R, Oldenburg J. Escuriola-Ettingshausen C, et al. Among authors: oldenburg j. Haemophilia. 2021 May;27(3):e305-e313. doi: 10.1111/hae.14010. Epub 2020 Sep 16. Haemophilia. 2021. PMID: 32937002 Review.

2

Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland.

Tiede A, Huth-Kühne A, Oldenburg J, Grossmann R, Geisen U, Krause M, Brand B, Alberio L, Klamroth R, Spannagl M, Knöbl P. Tiede A, et al. Among authors: oldenburg j. Ann Hematol. 2009 Apr;88(4):365-70. doi: 10.1007/s00277-008-0665-7. Epub 2008 Dec 16. Ann Hematol. 2009. PMID: 19083235 Free article.

3

Report of the Fifth meeting of the International Network for Pediatric Hemophilia: a focus on prophylaxis and immune tolerance induction.

Ljung R, Oldenburg J, Auerswald G, van den Berg M, Shima M, DiMichele D. Ljung R, et al. Among authors: oldenburg j. Int J Hematol. 2011 Oct;94(4):415-421. doi: 10.1007/s12185-011-0925-5. Epub 2011 Sep 28. Int J Hematol. 2011. PMID: 21953272 No abstract available.

4

Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort.

Caspers M, Pavlova A, Driesen J, Harbrecht U, Klamroth R, Kadar J, Fischer R, Kemkes-Matthes B, Oldenburg J. Caspers M, et al. Among authors: oldenburg j. Thromb Haemost. 2012 Aug;108(2):247-57. doi: 10.1160/TH11-12-0875. Epub 2012 May 25. Thromb Haemost. 2012. PMID: 22627591

5

Prophylaxis and quality of life in patients with hemophilia A during routine treatment with ADVATE [antihemophilic factor (recombinant), plasma/albumin-free method] in Germany: a subgroup analysis of the ADVATE PASS post-approval, non-interventional study.

Pollmann H, Klamroth R, Vidovic N, Kriukov AY, Epstein J, Abraham I, Spotts G, Oldenburg J. Pollmann H, et al. Among authors: oldenburg j. Ann Hematol. 2013 May;92(5):689-98. doi: 10.1007/s00277-013-1678-4. Epub 2013 Jan 17. Ann Hematol. 2013. PMID: 23324986

6

Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease.

Yadegari H, Driesen J, Pavlova A, Biswas A, Ivaskevicius V, Klamroth R, Oldenburg J. Yadegari H, et al. Among authors: oldenburg j. Haematologica. 2013 Aug;98(8):1315-23. doi: 10.3324/haematol.2013.084111. Epub 2013 Mar 28. Haematologica. 2013. PMID: 23539537 Free PMC article.

7

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.

Gouw SC, van den Berg HM, Fischer K, Auerswald G, Carcao M, Chalmers E, Chambost H, Kurnik K, Liesner R, Petrini P, Platokouki H, Altisent C, Oldenburg J, Nolan B, Garrido RP, Mancuso ME, Rafowicz A, Williams M, Clausen N, Middelburg RA, Ljung R, van der Bom JG; PedNet and Research of Determinants of INhibitor development (RODIN) Study Group. Gouw SC, et al. Among authors: oldenburg j. Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3. Blood. 2013. PMID: 23553768 Free article.

8

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Eckhardt CL, van Velzen AS, Peters M, Astermark J, Brons PP, Castaman G, Cnossen MH, Dors N, Escuriola-Ettingshausen C, Hamulyak K, Hart DP, Hay CR, Haya S, van Heerde WL, Hermans C, Holmström M, Jimenez-Yuste V, Keenan RD, Klamroth R, Laros-van Gorkom BA, Leebeek FW, Liesner R, Mäkipernaa A, Male C, Mauser-Bunschoten E, Mazzucconi MG, McRae S, Meijer K, Mitchell M, Morfini M, Nijziel M, Oldenburg J, Peerlinck K, Petrini P, Platokouki H, Reitter-Pfoertner SE, Santagostino E, Schinco P, Smiers FJ, Siegmund B, Tagliaferri A, Yee TT, Kamphuisen PW, van der Bom JG, Fijnvandraat K; INSIGHT Study Group. Eckhardt CL, et al. Among authors: oldenburg j. Blood. 2013 Sep 12;122(11):1954-62. doi: 10.1182/blood-2013-02-483263. Epub 2013 Aug 7. Blood. 2013. PMID: 23926300 Free article.

9

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF; A-LONG Investigators. Mahlangu J, et al. Blood. 2014 Jan 16;123(3):317-25. doi: 10.1182/blood-2013-10-529974. Epub 2013 Nov 13. Blood. 2014. PMID: 24227821 Free PMC article. Clinical Trial.

10

[Hamburg Hemophilia Symposium 2012].

Oldenburg J, Kurnik K. Oldenburg J, et al. Hamostaseologie. 2013;33 Suppl 1:S1. Hamostaseologie. 2013. PMID: 24344444 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

764 results

Search Page